Uhlenbruck empfahl (s
Severe gastrointestinal symptoms lasting more than 48 hours, inability to maintain adequate oral intake, or signs of dehydration (decreased urine output, extreme thirst, dry mucous membranes) require prompt evaluation
SCFA-induced GLP-1 and PYY release is at least partially dependent upon the GPR43 receptor pathway 113,281,282,283
Taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms
Marketing & Distribution Pharmaceutical companies develop marketing strategies targeted at healthcare professionals and patients to raise awareness about the benefits of GLP-1 therapies
Furthermore, treatment with Pluronic L-81, a surfactant that inhibits chylomicron formation, significantly attenuates the anorectic effects of intraduodenal lipids and attenuates both CCK release and celiac and cervical vagal afferent activation following lipid infusion 40,109,156,186